215 related articles for article (PubMed ID: 12053022)
1. Significance of vitamin D receptor gene polymorphism for risk and disease severity of prostate cancer and benign prostatic hyperplasia in Japanese.
Hamasaki T; Inatomi H; Katoh T; Ikuyama T; Matsumoto T
Urol Int; 2002; 68(4):226-31. PubMed ID: 12053022
[TBL] [Abstract][Full Text] [Related]
2. Clinical and pathological significance of vitamin D receptor gene polymorphism for prostate cancer which is associated with a higher mortality in Japanese.
Hamasaki T; Inatomi H; Katoh T; Ikuyama T; Matsumoto T
Endocr J; 2001 Oct; 48(5):543-9. PubMed ID: 11789558
[TBL] [Abstract][Full Text] [Related]
3. Association of vitamin D receptor gene polymorphism with prostate cancer and benign prostatic hyperplasia in a Japanese population.
Habuchi T; Suzuki T; Sasaki R; Wang L; Sato K; Satoh S; Akao T; Tsuchiya N; Shimoda N; Wada Y; Koizumi A; Chihara J; Ogawa O; Kato T
Cancer Res; 2000 Jan; 60(2):305-8. PubMed ID: 10667581
[TBL] [Abstract][Full Text] [Related]
4. Vitamin D receptor polymorphisms and lethal prostate cancer.
Kibel AS; Isaacs SD; Isaacs WB; Bova GS
J Urol; 1998 Oct; 160(4):1405-9. PubMed ID: 9751364
[TBL] [Abstract][Full Text] [Related]
5. Vitamin D receptor, HER-2 polymorphisms and risk of prostate cancer in men with benign prostate hyperplasia.
Tayeb MT; Clark C; Haites NE; Sharp L; Murray GI; McLeod HL
Saudi Med J; 2004 Apr; 25(4):447-51. PubMed ID: 15083213
[TBL] [Abstract][Full Text] [Related]
6. Polymorphisms in the vitamin D receptor gene and the androgen receptor gene and the risk of benign prostatic hyperplasia.
Bousema JT; Bussemakers MJ; van Houwelingen KP; Debruyne FM; Verbeek AL; de La Rosette JJ; Kiemeney LA
Eur Urol; 2000 Feb; 37(2):234-8. PubMed ID: 10705205
[TBL] [Abstract][Full Text] [Related]
7. Vitamin D receptor gene polymorphism and prostate cancer risk.
Gsur A; Madersbacher S; Haidinger G; Schatzl G; Marberger M; Vutuc C; Micksche M
Prostate; 2002 Apr; 51(1):30-4. PubMed ID: 11920955
[TBL] [Abstract][Full Text] [Related]
8. Significance of vitamin D receptor gene polymorphism for prostate cancer risk in Japanese.
Watanabe M; Fukutome K; Murata M; Uemura H; Kubota Y; Kawamura J; Yatani R
Anticancer Res; 1999; 19(5C):4511-4. PubMed ID: 10650802
[TBL] [Abstract][Full Text] [Related]
9. Increased risk of prostate cancer and benign prostatic hyperplasia associated with a CYP17 gene polymorphism with a gene dosage effect.
Habuchi T; Liqing Z; Suzuki T; Sasaki R; Tsuchiya N; Tachiki H; Shimoda N; Satoh S; Sato K; Kakehi Y; Kamoto T; Ogawa O; Kato T
Cancer Res; 2000 Oct; 60(20):5710-3. PubMed ID: 11059764
[TBL] [Abstract][Full Text] [Related]
10. Association of vitamin D receptor gene polymorphism with renal cell carcinoma in Japanese.
Ikuyama T; Hamasaki T; Inatomi H; Katoh T; Muratani T; Matsumoto T
Endocr J; 2002 Aug; 49(4):433-8. PubMed ID: 12402975
[TBL] [Abstract][Full Text] [Related]
11. CYP3A4 and VDR gene polymorphisms and the risk of prostate cancer in men with benign prostate hyperplasia.
Tayeb MT; Clark C; Haites NE; Sharp L; Murray GI; McLeod HL
Br J Cancer; 2003 Mar; 88(6):928-32. PubMed ID: 12644831
[TBL] [Abstract][Full Text] [Related]
12. Vitamin D receptor gene polymorphism in Japanese patients with prostate cancer.
Furuya Y; Akakura K; Masai M; Ito H
Endocr J; 1999 Jun; 46(3):467-70. PubMed ID: 10504001
[TBL] [Abstract][Full Text] [Related]
13. Polymorphisms of fibroblast growth factor receptor 4 have association with the development of prostate cancer and benign prostatic hyperplasia and the progression of prostate cancer in a Japanese population.
Ma Z; Tsuchiya N; Yuasa T; Inoue T; Kumazawa T; Narita S; Horikawa Y; Tsuruta H; Obara T; Saito M; Satoh S; Ogawa O; Habuchi T
Int J Cancer; 2008 Dec; 123(11):2574-9. PubMed ID: 18756523
[TBL] [Abstract][Full Text] [Related]
14. Association of genetic variants of the vitamin D receptor (VDR) gene (Fok-I, Taq-I and Bsm-I) with susceptibility of benign prostatic hyperplasia in a North Indian population.
Manchanda PK; Konwar R; Nayak VL; Singh V; Bid HK
Asian Pac J Cancer Prev; 2010; 11(4):1005-8. PubMed ID: 21133615
[TBL] [Abstract][Full Text] [Related]
15. Increased risk of prostate cancer and benign prostatic hyperplasia associated with transforming growth factor-beta 1 gene polymorphism at codon10.
Li Z; Habuchi T; Tsuchiya N; Mitsumori K; Wang L; Ohyama C; Sato K; Kamoto T; Ogawa O; Kato T
Carcinogenesis; 2004 Feb; 25(2):237-40. PubMed ID: 14604900
[TBL] [Abstract][Full Text] [Related]
16. Association of V89L SRD5A2 polymorphism with prostate cancer development in a Japanese population.
Li Z; Habuchi T; Mitsumori K; Kamoto T; Kinoshitu H; Segawa T; Ogawa O; Kato T
J Urol; 2003 Jun; 169(6):2378-81. PubMed ID: 12771801
[TBL] [Abstract][Full Text] [Related]
17. Association of codon 10 polymorphism of the transforming growth factor beta 1 gene with prostate cancer and hyperplasia in an Iranian population.
Omrani MD; Taghipour-Bazargani S; Salari-Lak S; Bagheri M
Urol Int; 2009; 83(3):329-32. PubMed ID: 19829035
[TBL] [Abstract][Full Text] [Related]
18. Vitamin D receptor polymorphisms and prostate cancer.
Blazer DG; Umbach DM; Bostick RM; Taylor JA
Mol Carcinog; 2000 Jan; 27(1):18-23. PubMed ID: 10642433
[TBL] [Abstract][Full Text] [Related]
19. Catechol-O-methyltransferase gene polymorphisms in benign prostatic hyperplasia and sporadic prostate cancer.
Tanaka Y; Sasaki M; Shiina H; Tokizane T; Deguchi M; Hirata H; Hinoda Y; Okayama N; Suehiro Y; Urakami S; Kawakami T; Kaneuchi M; Pookot D; Igawa M; Okuyama A; Ishii N; Dahiya R
Cancer Epidemiol Biomarkers Prev; 2006 Feb; 15(2):238-44. PubMed ID: 16492910
[TBL] [Abstract][Full Text] [Related]
20. Prostate-specific antigen and 17-hydroxylase polymorphic genotypes in patients with prostate cancer and benign prostatic hyperplasia.
Gunes S; Bagci H; Sarikaya S; Bilen CY; Kara N
DNA Cell Biol; 2007 Dec; 26(12):873-8. PubMed ID: 17961073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
